GSK on Wednesday said it was "well positioned" to absorb potential U.S. pharmaceutical tariffs, citing AI-driven cost cuts ...

U.S.-listed shares of GSK are gaining in intraday trading Wednesday after the British pharma giant posted ...

GlaxoSmithKline Pharmaceuticals, operating in the Pharmaceuticals sector and classified as a Midcap on the BSE, currently has its share price at ₹2800.7. The stock has experienced fluctuations ...

This is currently the only GSK product in the top 20 biggest selling drugs, and analysts Evaluate Pharma say this situation will not improve over the next five years. Skip to main content ...

CuraTeQ Biologics s.r.o., announced that the CHMP of the European Medicines Agency has adopted a positive opinion ...

But GSK is only looking at the business Walmsley said the “we don’t need it and we won’t overpay for it," - and also pledged that its most important division, pharma, would not lose out on ...

The Board of Directors of Kirloskar Pneumatic Company Limited, at its meeting held today have approved the financial results ...

GlaxoSmithKline Pharmaceuticals share price today: Shares of GlaxoSmithKline Pharmaceuticals (GSK Pharma) hit an all-time high of ₹3,147.45, surging 10 per cent on the BSE in Thursday’s intra-day ...

Suven Pharmaceuticals, operating in the Pharmaceuticals sector and classified as a Midcap on the BSE, currently has its share price at ₹1138.65. The stock has experienced fluctuations today ...

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.